Thomas Engleitner

6.7k citations
75 papers · 5.0k · 4 hit papers · h-index 29

Impact in

  • Hepatology top 1%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Immunology top 2%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Immune Cell Function and Interaction 10
    • Immune cells in cancer 5
    • Immunotherapy and Immune Responses 5
    • T-cell and B-cell Immunology 5
    • Immune Response and Inflammation 4
    • Pancreatic and Hepatic Oncology Research 6
    • Cancer Cells and Metastasis 4

Thomas Engleitner

73 papers receiving 4.9k citations

Thomas Engleitner's Hit Papers

NASH limits anti-tumour surveillance in immunotherapy-treated HCC 2021 · 1.0k citations
1.0k0+3+6Years since publication2505007501000

Peers

Thomas Engleitner
Comparison fields: 5 of 113
  • Hepatology 652
  • Immunology 1.2k
  • Oncology 1.3k
  • Cancer Research 609
  • Molecular Biology 2.0k
Replace Yasuharu Nishimura with:
Yasuharu Nishimura Japan
Subburaj Ilangumaran Canada
Frank Leithäuser Germany
Alan C. Mullen United States
Pinglong Xu China
Akio Matsuzawa Japan
Marie‐Annick Buendia France
Stuart A.C. McDonald United Kingdom
David Maag United States
Marilyn R. Kehry United States
Thomas Engleitner relative to Yasuharu Nishimura Japan Yasuharu Nishimura's profile →
Citations per field
00.5×2×3×4×5.0×
Yasuharu Nishimura · 1×
Citations per year

Countries citing papers authored by Thomas Engleitner

Since Specialization
Citations

This map shows the geographic impact of Thomas Engleitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Engleitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Engleitner more than expected).

Fields of papers citing papers by Thomas Engleitner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Engleitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Engleitner. The network helps show where Thomas Engleitner may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Engleitner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Engleitner Line = papers co-authored together Thomas Engleitner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#Work
1
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Hit paper breakdown →
20211006
2
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Hit paper breakdown →
2016553
3
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
Hit paper breakdown →
2021500
4
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Hit paper breakdown →
2019338
5 2018323
6 2016169
7 2015158
8 2016142
9 2019107
10 201892
11 202187
12 201971
13 202066
14 202061
15 202159
16 201755
17 201455
18 202355
19 202452
20 201646

About Thomas Engleitner

Thomas Engleitner is a scholar working on Immunology, Oncology, Cancer Research, Molecular Biology and Parasitology, having authored 75 papers that have together received 5.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (10 papers), Cancer Genomics and Diagnostics (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Immune cells in cancer (5 papers), Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (5 papers), Cancer Cells and Metastasis (4 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Hepatology (652 citations), Immunology (1.2k citations), Oncology (1.3k citations), Cancer Research (609 citations) and Molecular Biology (2.0k citations). Thomas Engleitner has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Roland Rad, Julia Weber, Richard Klar, Julia Slotta‐Huspenina, Katja Specht, Stefan Audehm, Marc Eric Martignoni, Melanie Straub, Eva Bräunlein and Christian Peschel. Their work appears in journals such as Nature Communications, Nature, Scientific Reports, Malaria Journal and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact